SCHEMBL4015598

SCHEMBL4015598

O=C([O-])CNCC(=O)[O-].[Cu+2]

nearest known ligand 0.50

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CA4 P22748 2/20 0.50
CA1 P00915 4/20 0.42
CA12 O43570 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
FFAR3 O14843 2/20 0.40
HDAC3 O15379 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC8 Q9BY41 2/20 0.40
CASP1 P29466 1/20 0.37
BBOX1 O75936 1/20 0.36
FABP3 P05413 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28389261 0.97 CA4 (0.47) CA4CA1CA12CA2CA9
SCHEMBL10453183 0.94 CA4 (0.44) CA4CA1CA12CA2CA9
SCHEMBL1882178 0.93 CA4 (0.50) CA4CA1CA12CA2CA9
SCHEMBL329100 0.93 CA4 (0.50) CA4CA1CA12CA2CA9
Silver SCHEMBL17818673 0.93 CA4 (0.50) CA4CA1CA12CA2CA9
SCHEMBL2947828 0.93 CA4 (0.50) CA4CA1CA12CA2CA9
Lithium Ion SCHEMBL3464173 0.93 CA4 (0.50) CA4CA1CA12CA2CA9
SCHEMBL10627868 0.93 CA4 (0.50) CA4CA1CA12CA2CA9
Zinc Ion SCHEMBL9393640 0.93 CA4 (0.50) CA4CA1CA12CA2CA9
SCHEMBL5183804 0.93 CA4 (0.50) CA4CA1CA12CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263686-A1 METHODS OF INHIBITING NUCLEASE ACTIVITY, METHODS OF ISOLATING NUCLEI FROM CELLS, AND METHODS FOR EXTENDING DNA NATIONAL CHENG KUNG UNIVERSITY (TW) 2025-08-21 US claimed
WO-2000010007-A9 DEVICES AND METHODS FOR ANALYSIS OF NON-IONIC SOLUTES CALIFORNIA INST OF TECHN (US) 2000-07-06 WO claimed
US-6063637-A SENSING MATERIAL OF METAL COMPLEXES HAVING AT LEAST TWO COORDINATION SITES FOR BINDING TARGET AND A DETECTOR FOR MEASURING THE PROTONS OR HYDROXIDE IONS RELEASED FROM THE SENSING MATERIAL WHEN ANALYTE IS BOUND CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-05-16 US claimed
WO-2000010007-A2 DEVICES AND METHODS FOR ANALYSIS OF NON-IONIC SOLUTES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-02-24 WO claimed
US-20260101895-A1 FUNGICIDAL AGENT AND COMPOSITION INNOSPEC LTD (GB) 2026-04-16 US disclosed
US-20250263686-A1 METHODS OF INHIBITING NUCLEASE ACTIVITY, METHODS OF ISOLATING NUCLEI FROM CELLS, AND METHODS FOR EXTENDING DNA NATIONAL CHENG KUNG UNIVERSITY (TW) 2025-08-21 US disclosed
CN-116040782-A Method for regulating generation and in-situ utilization of Cu (III) and application thereof 温州大学 2023-05-02 CN disclosed
CN-111278998-A Method for recovering cobalt, lithium and other metals from spent lithium-based batteries and other feeds 城市采矿有限公司 2020-06-12 CN disclosed
US-20090171052-A1 Polyelectrolyte Monolayers and Multilayers for Optical Signal Transducers SIEMENS MEDICAL SOLUTIONS DIAGNOSTICS GMBH (US) 2009-07-02 US disclosed
US-7517705-B2 Coating a dielectric waveguide with a polymer such as the reaction product of polyethylene glycol methyl ether acrylate, vinylphosphonic acid, and methacryloxyethyl acetoacetate; used for biosensors and chemosensors BAYER AKTIENGESELLSCHAFT (DE) 2009-04-14 US disclosed
US-20060287453-A1 Coating a dielectric waveguide with a polymer such as the reaction product of polyethylene glycol methyl ether acrylate, vinylphosphonic acid, and methacryloxyethyl acetoacetate; used for biosensors and chemosensors BAYER AKTIENGESELLSCHAFT (DE) 2006-12-21 US disclosed
US-7101945-B2 for coating dielectric materials BAYER AKTIENGESELLSCHAFT (DE) 2006-09-05 US disclosed
US-20020114604-A1 Phosphorus-containing polymers for optical signal transducers BAYER INTELLECTUAL PROPERTY GMBH (DE) 2002-08-22 US disclosed
WO-2000010007-A9 DEVICES AND METHODS FOR ANALYSIS OF NON-IONIC SOLUTES CALIFORNIA INST OF TECHN (US) 2000-07-06 WO disclosed
US-6063637-A SENSING MATERIAL OF METAL COMPLEXES HAVING AT LEAST TWO COORDINATION SITES FOR BINDING TARGET AND A DETECTOR FOR MEASURING THE PROTONS OR HYDROXIDE IONS RELEASED FROM THE SENSING MATERIAL WHEN ANALYTE IS BOUND CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-05-16 US disclosed
WO-2000010007-A2 DEVICES AND METHODS FOR ANALYSIS OF NON-IONIC SOLUTES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2000-02-24 WO disclosed
US-5484702-A Method for preselecting recombinant clones containing a specific nucleic acid sequence and subsequent transformation with preselected clones RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK AT BUFFALO (US) 1996-01-16 US disclosed
WO-1995020677-A1 METHOD FOR PRESELECTING RECOMBINANT CLONES CONTAINING A SPECIFIC NUCLEIC ACID SEQUENCE AND SUBSEQUENT TRANSFORMATION WITH PRESELECTED CLONES RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AT BUFFALO (US) 1995-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260101895-A1 FUNGICIDAL AGENT AND COMPOSITION SLC7A1, AOC1, AOC2 CA4 428/4885CA1 283/4885CA12 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.